Conduit Pharmaceuticals Files 8-K: Accountant Change & Financials

Ticker: CDTTW · Form: 8-K · Filed: Apr 25, 2025 · CIK: 1896212

Conduit Pharmaceuticals Inc. 8-K Filing Summary
FieldDetail
CompanyConduit Pharmaceuticals Inc. (CDTTW)
Form Type8-K
Filed DateApr 25, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: auditor-change, financials

TL;DR

Conduit Pharma changed auditors and filed financials. Keep an eye on their next moves.

AI Summary

Conduit Pharmaceuticals Inc. filed an 8-K on April 25, 2025, reporting changes in its certifying accountant and filing financial statements and exhibits. The company, formerly known as Murphy Canyon Acquisition Corp. until November 30, 2021, is incorporated in Delaware and based in Naples, Florida.

Why It Matters

This filing indicates a change in the company's auditor, which can sometimes signal shifts in financial reporting or internal controls. The inclusion of financial statements provides an update on the company's financial health.

Risk Assessment

Risk Level: medium — Changes in certifying accountants can sometimes precede or coincide with financial irregularities or a change in strategic direction, warranting closer scrutiny.

Key Players & Entities

  • Conduit Pharmaceuticals Inc. (company) — Registrant
  • Murphy Canyon Acquisition Corp. (company) — Former company name
  • November 30, 2021 (date) — Date of name change
  • April 24, 2025 (date) — Earliest event reported date
  • April 25, 2025 (date) — Filing date

FAQ

Who is Conduit Pharmaceuticals Inc.'s new certifying accountant?

The filing does not explicitly name the new certifying accountant, only that there has been a change.

What specific financial statements and exhibits were filed?

The filing indicates that financial statements and exhibits were filed, but the specific details are not provided in this summary section.

When did Conduit Pharmaceuticals Inc. change its name from Murphy Canyon Acquisition Corp.?

The company changed its name on November 30, 2021.

What is the business address of Conduit Pharmaceuticals Inc.?

The business address is 4851 Tamiami Trail North, Suite 200, Naples, FL 34103.

What is the SIC code for Conduit Pharmaceuticals Inc.?

The Standard Industrial Classification (SIC) code is 2834 for Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 25, 2025 regarding CONDUIT PHARMACEUTICALS INC. (CDTTW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.